Obstetrics Gynecology and Reproduction,
Journal Year:
2023,
Volume and Issue:
16(6), P. 692 - 705
Published: Jan. 14, 2023
More
than
two
year-experience
in
monitoring
patients
with
severe
novel
coronavirus
disease
revealed
an
increased
risk
of
macroand
microcirculatory
thrombosis,
clinically
manifested
by
heart
attack,
stroke,
thromboses
rare
localizations
(thrombosis
the
hepatic
veins,
mesenteric
cerebral
sinuses,
portal
vein),
being
main
cause
adverse
outcomes.
Thromboembolic
complications,
expressed
as
sepsis-induced
coagulopathy,
disseminated
intravascular
coagulation,
venous
and
arterial
thromboembolism,
pulmonary
embolism,
microthrombosis,
thrombotic
microangiopathy
were
noted
to
affect
various
organs
such
lungs,
heart,
kidneys,
brain.
Earlier,
we
showed
that
hypercoagulability
is
closely
related
inflammatory
diseases
hemostasis
dysregulation.
Endothelial
injury
dysfunction
have
been
identified
critical
pathways
other
mechanisms
occurring
microvasculature
described
endothelial
activation,
cytokine
storm,
formation
neutrophil
extracellular
traps
(NETs).
However,
a
role
platelets
COVID-19
has
not
examined.
Platelets
are
small
non-nucleated
cells
most
known
central
mediators
hemostasis.
upon
release
variety
immunomodulatory
cytokines
chemokines
involved
regulating
immune
response.
Because
both
immunity
they
play
immunothrombosis,
physiological
process
wherein
induce
microthrombogenesis
prevent
spread
pathogens
facilitate
their
clearance.
Moreover,
can
directly
interact
viral
receptors
including
those
SARS-CoV-2.
Platelet
includes
thrombocytopenia
platelet
hyperactivation.
It
should
be
persistent
usually
correlated
mortality
associated
thrombosis
splanchnic
system,
autoimmune
reactions,
well
administered
heparin
vaccines.
Therefore,
here
review
pathogenesis
COVID-19.
Medicina,
Journal Year:
2025,
Volume and Issue:
61(4), P. 634 - 634
Published: March 30, 2025
Background
and
Objectives:
The
neutrophil-to-lymphocyte
ratio
(NLR)
platelet-to-lymphocyte
(PLR)
are
novel
biomarkers
that
provide
insight
into
systemic
inflammation
how
the
immune
system
responds
to
stress
or
infection.
These
ratios
have
been
associated
with
predicting
clinical
outcomes
in
various
diseases,
including
COVID-19.
This
study
aims
evaluate
prognostic
value
of
NLR
PLR
anticipating
ICU
admission,
acute
respiratory
failure,
disease
severity
COVID-19
patients.
Materials
Methods:
We
conducted
a
retrospective,
observational
included
536
patients
diagnosed
analyzed
values
at
admission
correlated
them
onset
outcomes.
Results:
Statistical
correlations
were
identified
between
elevated
development
complications
during
hospitalization
(p
=
0.04
p
0.00),
hypoxemic
failure
intensive
care
unit
(ICU)
0.04).
No
found
these
mortality
0.46
0.32)
nor
hepatic
cytolysis
0.79
0.87).
Conclusions:
reliable,
easily
obtainable
can
aid
early
prediction
patients,
offering
valuable
insights
for
risk
stratification
management.
Further
prospective
studies
needed
validate
as
part
broader
predictive
model
critical
Medical Microbiology and Immunology,
Journal Year:
2022,
Volume and Issue:
212(2), P. 185 - 191
Published: July 23, 2022
Infection
with
the
pandemic
human
coronavirus
SARS-CoV-2
elicits
a
respiratory
tract
disease,
termed
Coronavirus
disease
2019
(COVID-19).
While
variable
degree
of
disease-associated
symptoms
may
emerge,
severe
COVID-19
is
commonly
associated
complications
such
as
acute
distress
syndrome
(ARDS),
necessity
for
mechanical
ventilation
or
even
extracorporeal
membrane
oxygenation
(ECMO).
Amongst
others,
outcome
depends
on
age
and
pre-existing
conditions
like
cardiovascular
diseases,
metabolic
disorders
but
also
biological
sex.
Intriguingly,
increasing
experimental
clinical
evidence
suggests
that
an
exacerbated
inflammatory
response
in
particular
IgG
immune
complexes
(ICs),
significantly
contribute
to
prolonged
progression.
Vast
amounts
deposited,
unresolved
ICs
tissue
are
capable
initiate
exaggerated
Fc
gamma
receptor
(FcγR)
mediated
signalling
cascade
which
eventually
results
common
IC-associated
organ
diseases
vasculitis,
glomerulonephritis
arthritis,
comorbidities
have
been
frequently
reported
COVID-19.
Moreover
independent
deposited
ICs,
very
recent
work
identified
soluble
(sIC)
be
present
circulation
majority
severely
ill
patients,
where
their
systemic
abundance
correlated
severity.
Thus,
detection
circulating
sICs
patients
represents
potential
marker
critical
Their
early
after
deterioration
might
become
indicator
requirement
prompt
anti-inflammatory
treatment.
Here,
we
review
role
progression,
possible
origins
intervention
strategies.
Expert Review of Vaccines,
Journal Year:
2022,
Volume and Issue:
21(10), P. 1377 - 1394
Published: Aug. 20, 2022
Introduction
Since
its
emergence,
there
have
been
huge
efforts
to
design
vaccines
against
coronavirus
disease
2019
(COVID-19)
inhibit
interpersonal
spread.
Global
vaccine
development
is
the
most
promising
cost-effective
method
for
overcoming
epidemic.
However,
following
reports
of
post-vaccination
thromboembolic
adverse
effects,
raising
concerns
about
safety
profile
COVID-19
vaccine.Areas
covered
We
aimed
review
recent
Food
and
Drug
Administration
(FDA)-approved
identify
organ-based
major
complications
based
on
reliable
published
studies.
To
find
high-quality
large-scale
observational,
clinical
trial,
cohort
studies,
PubMED,
Scholar,
Embase,
Web
Science
were
searched
using
keywords:
COVID-19,
SARS-CoV-2,
vaccine,
Pfizer
(BNT162b2),
Johnson
(Ad26.COV2),
Moderna
(mRNA-1273),
Oxford
AstraZeneca
(ChAdOx1nCoV19),
Coronavac
(Sinovac),
BBIBP-CorV
(Sinopharm),
effect,
complication.
include
all
relevant
articles,
backward
searching
was
also
done
similar
article
citations.
Case
reports,
studies
including
less
than
10
participants,
biased
articles
excluded.Expert
opinion
Based
data
from
population-based
effects
are
divided
into
four
organ-specific
groups,
cardiovascular,
neurologic,
hematologic,
immune-allergic
side
effects.
The
incidence
these
not
different
between
vaccinated
normal
populations,
currently,
benefits
vaccination
greater
mortality
morbidity
risks
infection.
further
specifically
systematic
meta-analysis,
still
indicated
investigate
unknown
existence
causality
reported
events.
British Journal of Haematology,
Journal Year:
2022,
Volume and Issue:
200(4), P. 404 - 419
Published: Oct. 6, 2022
Summary
Numerous
studies
have
shown
peculiar
morphological
anomalies
in
COVID‐19
patients'
smears.
We
searched
all
the
peer‐reviewed
scientific
publications
that
explicitly
reference
cytomorphological
alterations
on
peripheral
blood
smears
of
patients
with
COVID‐19.
extracted
data
from
sixty‐five
(case
reports,
patient
group
studies,
reviews,
and
erythrocyte
morphology
studies).
The
results
show
frequent
concern
lymphocytes
(large
weakly
basophilic
cytoplasm,
plasmacytoid
lymphocytes,
large
granular
lymphocytes).
Neutrophils
display
abnormal
nuclei
cytoplasm
a
distinctive
picture.
Besides
left
shift
maturation,
granulations
can
be
increased
(toxic
type)
or
decreased
areas
basophilia.
Nuclei
are
often
hyposegmented
(pseudo‐Pelger‐Huёt
anomaly).
Apoptotic
pycnotic
cells
not
uncommon.
Monocytes
typically
loaded
heterogeneous
coalescing
vacuoles.
Platelets
giant
shapes.
presence
fragments
schistocytes
is
especially
evident
forms
associated
thrombotic
microangiopathies.
Such
atypia
reflects
generalized
activation
severe
COVID‐19,
which
has
been
demonstrated
immunophenotypic,
molecular,
genetic,
functional
methods.
Neutrophils,
particular,
involved
pathophysiology
hyperinflammation
cytokine
storm,
characterizes
most
unfavorable
evolution.
Thrombosis Journal,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: July 22, 2024
Abstract
Thrombocytopenia
frequently
occurs
in
patients
with
sepsis.
Disseminated
intravascular
coagulation
(DIC)
may
be
a
possible
cause
of
thrombocytopenia
owing
to
its
high
prevalence
and
association
poor
outcomes;
however,
it
is
important
keep
the
presence
other
diseases
mind
sepsis
practice.
Thrombotic
microangiopathy
(TMA),
which
characterized
by
thrombotic
thrombocytopenic
purpura,
Shiga
toxin-producing
Escherichia
coli
hemolytic
uremic
syndrome
(HUS),
complement-mediated
HUS,
thrombocytopenia,
microangiopathic
anemia,
organ
damage.
TMA
has
become
widely
recognized
recent
years
because
development
specific
treatments.
Previous
studies
have
reported
remarkably
lower
than
DIC;
epidemiology
not
well
defined,
there
cases
correctly
diagnosed,
resulting
outcomes.
Therefore,
differentiate
DIC
from
TMA.
Nevertheless,
differentiating
between
remains
challenge
as
indicated
previous
reports
that
most
can
diagnosed
using
universal
scoring
system.
Several
algorithms
sepsis-related
been
suggested,
contributing
improving
care
septic
thrombocytopenia;
difficult
apply
these
coexisting
TMA,
recently
reported.
This
review
describes
disease
characteristics,
including
epidemiology,
pathophysiology,
treatment,
DIC,
proposes
novel
practical
approach
flow,
initiation
diagnosis
parallel
DIC.
flow
also
refers
longitudinal
treatment
real
clinical
timeframes.
In
conclusion,
we
aim
disseminate
results
this
emphasize
importance
incorporating
consideration
management
We
anticipate
new
for
diagnostic
will
lead
appropriate
complex
cases,
improve
patient
outcomes,
generate
epidemiological
evidence
regarding
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 21, 2022
Roles
of
platelets
during
infections
surpass
the
classical
thrombus
function
and
are
now
known
to
modulate
innate
immune
cells.
Leukocyte-platelet
aggregations
activation-induced
secretome
among
factors
recently
gaining
interest
but
little
is
about
their
interplay
with
severity
mortality
course
SARS-Cov-2
infection.
The
aim
present
work
follow
platelets'
bioenergetics,
redox
balance,
calcium
homeostasis
as
regulators
leukocyte-platelet
interactions
in
a
cohort
COVID-19
patients
variable
clinical
outcomes.
We
investigated
infection-related
changes
platelet
counts,
activation,
morphology
(by
flow
cytometry
electron
microscopy),
bioenergetics
Seahorse
analyzer),
mitochondria
high
resolution
respirometry),
intracellular
cytometry),
reactive
oxygen
species
(ROS,
by
aggregates
cytometry)
non-intensive
care
unit
(ICU)
hospitalized
(Non-ICU,
n=15),
ICU-survivors
severe
(ICU-S,
n=35),
non-survivors
(ICU-NS,
n=60)
relative
control
subjects
(n=31).
Additionally,
molecular
studies
were
carried
out
gene
protein
expressions
mitochondrial
transport
chain
complexes
(ETC)
representative
samples
isolated
from
studied
groups.
Our
results
revealed
that
infection
leads
global
metabolic
depression
especially
despite
lack
significant
impacts
on
levels
ETC
genes
proteins.
also
report
patients'
exhibit
hyperpolarized
significantly
lowered
calcium,
concomitantly
increased
neutrophil.
These
associated
populations
giant
morphological
transformations
usually
correlated
activation
inflammatory
signatures,
impaired
exocytosis.
data
suggest
hyperactive
exocytosis
may
be
integral
parts
pathophysiology
dictating
patients.
Frontiers in Cardiovascular Medicine,
Journal Year:
2023,
Volume and Issue:
9
Published: Jan. 10, 2023
Background
and
purpose
Acute
ischemic
stroke
(AIS)
is
a
fearful
complication
of
Coronavirus
Disease-2019
(COVID-19).
Aims
this
study
were
to
compare
clinical/radiological
characteristics,
endothelial
coagulation
dysfunction
between
acute
patients
with
without
COVID-19
investigate
if
how
the
SARS-CoV-2
spike
protein
(SP)
was
implicated
in
triggering
platelet
activation.
Methods
We
enrolled
AIS
within
12
h
from
onset
compared
them
an
age-
sex-matched
cohort
controls
COVID-19.
Neuroimaging
studies
performed
24
h.
Blood
samples
collected
subset
10
patients.
Results
Of
39
patients,
22
had
17
did
not.
Admission
levels
Factor
VIII
von
Willebrand
factor
antigen
significantly
higher
positively
correlated
infarct
volume.
In
multivariate
linear
regression
analyses,
independent
predictor
volume
(B
20.318,
Beta
0.576,
95%CI
6.077–34.559;
p
=
0.011).
SP
found
serum
2
examined
Platelets
healthy
donors
showed
similar
degree
procoagulant
activation
induced
by
non-COVID-19
patients'
sera.
The
anti-SP
anti-FcγRIIA
blocking
antibodies
no
effect
modulating
activity
both
groups.
Conclusions
infection
seems
play
major
role
endothelium
extension
during
AIS.
Medicina,
Journal Year:
2021,
Volume and Issue:
57(10), P. 997 - 997
Published: Sept. 22, 2021
SARS-CoV-2
induced
a
pandemic
that
is
reported
to
have
started
in
Asia
and
was
then
extended
other
countries
the
world.
Main
clinical
aspects
of
this
viral
infection
been
lung
injuries
with
severe
pneumonia
requiring
prolonged
hospitalization
associated
morbidities
such
as
venous
thromboembolism
and/or
superinfection
by
bacteria,
fungus
or
pests.
Immediately
there
need
develop
sustainable
therapeutic
strategy,
vaccination.
Vaccines
against
Covid-19,
fact,
exert
protective
action
for
common
people
reduce
diffusion.
Yet,
vaccination
large
number
raises
question
well-known
complication
several
types
vaccines;
immune
thrombocytopenia,
which
sometimes
thrombosis
well.
In
short
review,
we
summarized
mechanisms
involved
pathogenesis
vaccine-induced
prothrombotic
thrombocytopenia
thrombocytopenic
thrombosis.
Revista Española de Cardiología (English Edition),
Journal Year:
2024,
Volume and Issue:
77(7), P. 539 - 546
Published: Jan. 6, 2024
Hypercoagulability
and
thromboembolism
are
processes
that
arise
from
severe
acute
respiratory
syndrome
coronavirus
2
infection
responsible
for
a
high
degree
of
disease
2019
(COVID-19)-related
morbidity
mortality.
This
study
sought
to
assess
the
effect
antiplatelet
drugs
on
COVID-19
severity
(risk
hospitalization
mortality),
susceptibility
infection,
progression
COVID-19.